Abstract submissions are now closed.

MTIS 2022 has welcomed submissions of abstracts for original contribution to the field in the following topics listed below:

    • Epidemiology, comorbidity, outcomes and classification, including big data
    • General and organisational aspects of headache care
    • Genetics and biomarkers of headache disorders
    • Headache Pathophysiology: Basic Research
    • Headache Pathophysiology: Clinical Research
    • Headache Pathophysiology: Imaging
    • Migraine – acute therapy: Pharmacological and Device based
    • Migraine – preventive therapy: Pharmacological and Device based
    • Cluster headache and other TACs
    • Tension-type headache and other primary headaches (in line with ICHD-3 terminology '4. other primary headache disorders')
    • Medication overuse headache
    • Post-traumatic headache, COVID-associated headache
    • Idiopathic intracranial hypertension
    • Other secondary headaches
    • Paediatric headache
    • Post-traumatic headache
    • Psychological and behaviour factors

Important Dates

Submissions Accepted From

1 March 2022

Submission Deadline

1 June 2022, 12:00 Midday (BST)

Abstract Review

June 2022

Late Breaking Abstracts

There will be a chance to submit ‘late breaking’ abstracts from 4 July 2022 for two weeks – Details of this will follow in due course


Please click here to review the MTIS Abstract Guidelines.